A good year for European rheumatology

di Kvien, T K
Pubblicazione 2007

Treating rheumatoid arthritis

di Emery, Paul, Kvien, Tore K
Pubblicazione 2007

Comparisons of 7- to 78-joint ultrasonography scores: all different joint combinations show equal response to adalimumab treatment in patients with rheumatoid arthritis

di Hammer, Hilde Berner, Kvien, Tore K
Pubblicazione 2011

Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis

di Uhlig, T., Kvien, T. K., Jensen, J. L., Axell, T.
Pubblicazione 1999

Hand bone loss as an outcome measure in established rheumatoid arthritis: 2-year observational study comparing cortical and total bone loss

di Hoff, Mari, Haugeberg, Glenn, Kvien, Tore K
Pubblicazione 2007

Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group

di Halpern, M T, Cifaldi, M A, Kvien, T K
Pubblicazione 2008

EULAR expects further development in 2006

di Kvien, T K, van de Putte, L B A
Pubblicazione 2006

Controlling the obesity epidemic is important for maintaining musculoskeletal health

di Woolf, A D, Breedveld, F C, Kvien, T K
Pubblicazione 2006

Minimal clinically important improvement/difference (MCII/MCID) and patient acceptable symptom state (PASS): what do these concepts mean?

di Kvien, Tore K, Heiberg, Turid, Hagen, Kåre B
Pubblicazione 2007

Introducing RMD Open

di Cutolo, Maurizio, Burmester, Gerd R, Kvien, Tore K
Pubblicato in RMD Open (2015)

Patient participation as an integral part of patient-reported outcomes development ensures the representation of the patient voice: a case study from the field of rheumatology

di de Wit, M P T, Kvien, T K, Gossec, L
Pubblicato in RMD Open (2015)

Ultrasound of the hand is sufficient to detect subclinical inflammation in rheumatoid arthritis remission: a post hoc longitudinal study

di Hammer, Hilde Berner, Kvien, Tore K., Terslev, Lene
Pubblicato in Arthritis Res Ther (2017)

Intermetatarsal bursitis is frequent in patients with established rheumatoid arthritis and is associated with anti-cyclic citrullinated peptide and rheumatoid factor

di Hammer, Hilde Berner, Kvien, Tore K, Terslev, L
Pubblicato in RMD Open (2019)

Development and preliminary validation of the pancreatic cancer disease impact score

di Heiberg, Turid, Nordby, Tom, Kvien, Tore K, Buanes, Trond
Pubblicazione 2013

Natural killer (NK) cell activity of peripheral blood, synovial fluid, and synovial tissue lymphocytes from patients with rheumatoid arthritis and juvenile rheumatoid arthritis.

di Dobloug, J H, Førre, O, Kvien, T K, Egeland, T, Degré, M
Pubblicazione 1982

Bone mineral density in patients with hand osteoarthritis compared to population controls and patients with rheumatoid arthritis

di Haugen, I K, Slatkowsky‐Christensen, B, Ørstavik, R, Kvien, T K
Pubblicazione 2007

Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study

di Hoff, M, Kvien, T K, Kälvesten, J, Elden, A, Haugeberg, G
Pubblicazione 2008

Pain and psychological health status over a 10‐year period in patients with recent onset rheumatoid arthritis

di Ødegård, Sigrid, Finset, Arnstein, Mowinckel, Petter, Kvien, Tore K., Uhlig, Till
Pubblicazione 2007

Perception of Improvement in Patients With Rheumatoid Arthritis Varies With Disease Activity Levels at Baseline

di ALETAHA, D., FUNOVITS, J., WARD, M. M., SMOLEN, J. S., KVIEN, T. K.
Pubblicazione 2009

The soluble biomarker calprotectin (a S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with...

di Hammer, Hilde Berner, Fagerhol, Magne K, Wien, Tale Norbye, Kvien, Tore K
Pubblicazione 2011